Synthetic Genomics CEO J. Craig Venter

Synthetic Genomics CEO J. Craig Venter

Evan Hurd/J. Craig Venter Institute via Bloomberg

Synthetic Genomics Inc. Chief Executive Officer J. Craig Venter said the speed and accuracy of DNA-scanning machines increased to the point that for the first time makes massive clinically oriented sequencing efforts possible.